Related Experiment Video
Updated: Jul 20, 2026
11:12
Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
Small molecule oxidation products trigger disease-associated protein misfolding
Jan Bieschke1, Qinghai Zhang, Daryl A Bosco
1The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Accounts of Chemical Research
|September 20, 2006
Summary
Oxidative stress contributes to neurodegenerative diseases like Parkinson's and Alzheimer's by accelerating protein misassembly. Small molecule oxidation products in the brain promote the clumping of alpha-synuclein and amyloid-beta, driving disease progression.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Oxidative stress and inflammation are key risk factors for common neurodegenerative disorders.
- Alpha-synucleinopathies (Parkinson's, dementia with Lewy bodies) and Alzheimer's disease involve toxic protein aggregation.
- Most cases of these diseases are sporadic, lacking identifiable genetic mutations.
Purpose of the Study:
- To explore the mechanism by which small molecule oxidation products mediate protein misassembly.
- To investigate the role of specific oxidation products, secosterols and 4-hydroxynonenal, in protein aggregation.
- To identify potential intervention strategies against these disease pathways.
Main Methods:
- Analysis of oxidative stress markers in affected brain tissue.
- In vitro studies on the effects of secosterols and 4-hydroxynonenal on protein assembly.
- Investigation of cholesterol oxidation and lipid peroxidation pathways.
Main Results:
- Small molecule oxidation products, including secosterols and 4-hydroxynonenal, are present in afflicted brains.
- These oxidation products significantly accelerate the misassembly of both alpha-synuclein and amyloid-beta peptides.
- The findings highlight a common mechanistic pathway in distinct neurodegenerative diseases.
Conclusions:
- Small molecule oxidation products are critical accelerators of pathogenic protein misassembly in neurodegeneration.
- Targeting these oxidation products or their pathways may offer novel therapeutic strategies for Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
- Understanding this mechanism provides a unified view of sporadic neurodegenerative disease pathogenesis.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...